We showed that enhanced p21 levels suppressed autoreactivity and DN T cell lymphadenopathy in B6/lpr-p21tg mice and effectively targeted severe autoimmune disease and death in MRL/lpr-p21tg mice and led to three principal conclusions. Here, CDKN1A is linked to Lymphadenopathy.